Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Clinical trial NCT05051761 · COMPLETED
Trial details
- NCT number
- NCT05051761
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-04
- Primary completion
- 2023-12-27
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.